FOI release

Remicade (infliximab)

Some or all of the information requested may not have been provided because we determined that the request was vexatious.

Case reference FOI2025/00740

Received 18 July 2025

Published 9 September 2025

Request

I’m writing this email to submit a Freedom of Information (FOI) request for “Remicade (infliximab)_CSR (NCT00207675, NCT00336492)”. Requesting document is listed below and please let me know if you need additional information. Requesting documents ‘Remicade (infliximab)’ ▶ CSR for NCT00207675 (CD Pediatric Phase 3) ▶ CSR for NCT00336492 (UC Pediatric Phase 3)

Response

See attached

Documents

• FOI2025_00740 (redacted).pdf (796.2 KB)

This is Medicines and Healthcare products Regulatory Agency's response to a freedom of information (FOI) or environmental information regulations (EIR) request.

You can browse our other responses or make a new FOI request.